AM

Anjali Maheshwari

Active Director Director DIN 09502805
DIN 09502805 First appointment Feb 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Anjali Maheshwari

Data last updated:

Anjali Maheshwari is a Director at Preyuda Private Limited (since 2022). The company operates in Pharma. Preyuda Private Limited reported revenue of ₹1.42 Cr (FY 2025).

DIN 09502805
Primary Designation Director
Industry Pharma
First Appointment 11 Feb 2022
Oldest Company Age 4 yrs
Largest company Preyuda Private Limited · ₹1.42 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Preyuda Private Limited U24304MP2022PTC059557
Director11 Feb 20222022₹1.42 Cr (FY 2025)Active

Board colleagues of Anjali Maheshwari

NameDINCompanyDesignation
Himanshu Maheshwari09502804Preyuda Private LimitedDirector

Directorship timeline

Open interactive timeline →
Preyuda Private Limited
Premium access

Shareholding and investment profile for Anjali Maheshwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjali Maheshwari

Anjali Maheshwari currently holds 1 directorship: Preyuda Private Limited (Director, since 11 Feb 2022, revenue ₹1.42 Cr (FY 2025)).

Anjali Maheshwari was first appointed on 11 Feb 2022 as Director at Preyuda Private Limited.

The current boards of Anjali Maheshwari's companies include Himanshu Maheshwari (Preyuda Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available